and preparation in relation to patients with deseases affecting the central nervous system. Those patients may undergo various forms of surgery unrelated to the central nervous system disease. We discuss the effect of physiologic and pharmacological factors on cerebral autoregulation and control of intracranial pressure alongside its clinical relevance with the help of new evidence. Recent findings: Regardless of the reason for surgery, coexisting diseases of brain often have important implications when selecting anesthetic drugs, procedures and monitoring techniques. Suppression of cerebral metabolic rate is not the sole mechanism for the neuroprotective effect of anaesthetic agents. There are certain general principles, but also some specific circumstances, when we are talking about optimal anesthetic procedure for a patient with coexisting brain disease. Intravenous anesthesia, such as combination of propofol and remifentanil, provides best preservation of autoregulation. Among inhaled agents isoflurane and sevoflurane appear to preserve autoregulation at all doses, whereas with other agents autoregulation is impaired in a dose-related manner. During maintenance of anesthesia the patient is ventilated by intermittent positive pressure ventilation, at intermediate hyperventilation (PaCO2 25 -30 mmHg). Summary: Intraoperative cerebral autoregulation monitoring is an important consideration for the patients with coexisting neurological disease. Transcranial Doppler based static autoregulation measurements appears to be the most robust bedside method for this purpose.
INTRODUCTION
T he successful outcome of whatever surgical intervention on patient with coexisting brain disease has been balanced by three cornerstones:
• Understanding of pathophysiological circumstances connected to the certain brain disease;
• Influence of surgical intervention on dynamics of vascular and metabolic processes in central nervous system (CNS);
• Influence of anesthetic agents, most commonly with central depressant effects, on processes in cerebral vasculature and metabolism.
The brain has unique protection in human body. Its protection is complex, mechanical and physiological. The reason to it is small regenerative potential of cerebral structures. Solid cranial cage, blood brain barrier and cerebrospinal fluid circulation consist most important features of phylogenetically differentiated brain protection. Brain edema, intracranial pressure (ICP) increase, the blockade of cerebrospinal fluid circulation and consecutive development of hydrocephalus are the examples of protective brain mechanisms turning against vital interests of the whole body 1 . This review will examine the most important issues of preoperative evaluation and preparation of patients with deseases affecting the central nervous system who may undergo various forms of surgery unrelated to the central nervous system disease.
PHYSIOLOGICAL ASPECTS AND THE ASSESSMENT OF CENTRAL NERVOUS SYSTEM FUNCTIONS Circulation and metabolism of brain
Cerebral needs for oxygen and nutrients are vitally important to the whole body. That means the stability of cerebral blood flow (CBF) is conditio sine qua non for the human being to survive. Certain facts make cerebral circulation the unique within the cardiovascular system of the human body:
1. The ability of cerebrovascular system to autonomously regulate the volume of cerebral blood flow -cerebral autoregulation;
2. The existence of blood brain barrier; 3. The influence of brain placed in incompressible cranial cavity on brain tissue perfusion.
All anesthetic agents and procedures change, more or less, intracranial vascular dynamics. Regardless of primary insult that jeopardized brain function (trauma, tumor, occlusive or hemorrhagic cerebrovascular disease), interaction between anesthetic effects and altered cerebrovascular dynamics may create the insufficient cerebral perfusion and the ischemia as a common outcome of different pathological processes within CNS 2.
The importance of cerebral circulation arises from the disproportion between brain weight (2% of total body weight) and its participation in cardiac output (15%), i.e. basal oxygen availability (20%) 3 . Cerebral circulation usually has been divided in anterior (carotid) and posterior (vertebrobasilar) confluence. At the scull base those two vascular basins are connected by circle of Willis, anatomically rather diverse anastomotic system. This arterial ring acts as a great potential reserve of intracranial collateral circulation. Considering cerebral blood flow (CBF) most important factor is so called cerebral perfusion pressure (CPP) which stands as difference between mean arterial pressure (MAP) and intracranial pressure (ICP): CPP = MAP -IKP Within broad spectrum of arterial pressure values and physiological conditions, CBF remains practically unchanged. The majority of investigators estimate that, within CPP range of 50 -130 mmHg, there have been minimal changes of CBF. The regulation of CBF is also unique considering distribution of blood. 670 mL of total blood quantity that has been transferred to brain every minute (750 mL or 15 -20% of cardiac output in the resting condition) comes through anterior (carotid) circulation. Barely 80 mL comes through posterior (vertebrobasilar) circulation. Difference in distribution exists even between brain gray and white matter (64mL 100g Oxygen (O2) -evokes the increase of CBF not until it diminishes below 50 mmHg (PaO2), but then the increase of CBF is quite rapid. At 30 mmHg, the value of CBF is doubled. Conversely, the increase of PaO2 above normal range provokes only mild decrease of CBF. Breathing the pure oxygen, at 2 atm, one can diminish CBF only for 1/5. It has been proven clinically that keeping the patient at PaO2 above 80 mmHg is optimal to prevent the undesirable increase of CBF 5 . There have been many investigational results that indicate undesirable effects of excessive PaO2 elicited by stimulating the formation of harmful superoxides and peroxides 2, 6, 7 . Local tissue and blood physical and chemical factors -(concentration of hydrogen and potassium ions, pH, temperature). Since the famous study of Kety and Schmidt (1948) it has been known that acidosis evokes vasodilatation of cerebral vessels (increase of CBF) and alkalosis constriction (decrease of CBF) 4 . However, in the event of diabetic ketoacidosis those effects cannot be prevented by artificial decrease of PaCO2 (hyperventilation). Temperature is critically important for the value of CBF. Hypothermia decreases the rate of cerebral metabolism and of blood oxygen uptake. Hyperthermia acts conver-sely, i.e. CMRO2 and CBF increase approximately 5% for every new o C increment of body temperature 8 . As it is the case in the whole body, the importance of tissue hyperkalemia has been in signaling the appearance of cell death.
Increased intracranial pressure (ICP) is potent biomechanical factor of CBF change. It is quite obvious that pressure increase at the venous side of cerebral circulation leads to global reduction of CBF. The minimal cerebral perfusion pressure of 50 mmHg is needed to preserve adequate brain tissue oxygenation and nutrition. Why is it so in the brain, and not in systemic circulation, we can partially explain by histological structure of the brain and systemic veins. Providing minimal CBF the pressure in those veins has to be minimally greater than ambient ICP, otherwise they might have been collapsed provoking the cessation of circulation. It has been still unclear if that collapsing is ever clinically present and when? Some investigations had proven the permeance of those veins at the ICP values greater than 100 mmHg 9 . The major arteries in circle of Willis are main regulators of adaptation to systemic arterial pressure changes and bear the dominant part of cerebrovascular resistance. Those arteries react promptly to systemic arterial hypertension maintaining CBF stable.
However, in time, that ability of cerebral arteries might be obsolete. Chronic hypertonics, especially patients with arteriosclerosis, have autoregulation of cerebral circulation adapted to higher values of CPP. Thereafter, they become extremely sensitive to short episodes of hypotension (cerebral infarction). Whereas systemic disturbances of circulation evoke chronic alterations in structure and quality of blood vessels (including the creation of aneurysmatic bags), they become sensible even to short episodes of hypertension (intracerebral hemorrhage). (Picture 2).
Cerebral blood flow measurement
Contemporary investigations have been directed to retrogradly placing thermodilutional catheter and Doppler ultrasound device at internal jugular vein bulb. In the meantime, the procedure has become clinically feasible in cardiovascular theatres and easily reproducible even in neurosurgical operating rooms. Transcranial NIRS (NearInfraRed Spectroscopy) has been very promising, owing to its noninvasiveness. Although semiquantitative it enables registration of CBF alterations 10 .
In routine practice only transcranial Doppler ultrasonography proved useful owing to its availability to measure the diameter of major arteries at scull base and the velocity of bloodstream through them. Under conditions of exact localization and the optimal "echo" angle of the vessel the velocity of bloodstream is well correlated to the global CBF in the basin of monitored artery. And, what is maybe more important, the procedure is noninvasive and relatively unexpensive 11 .
Intracranial pressure -monitoring and control capabilities
Intracranial hypertension is not only common complication of severe head trauma (SHT), but of whole spectrum of other intracranial pathological processes. More than half lethal outcomes after SHT have been attributed to intracranial hypertension 12 . Increased ICP acts undesirably by decreasing cerebral perfusion pressure (CPP) and CBF under critical values of cerebral autoregulation, i.e. 60 mmHg of mean arterial pressure, resulting in ischemic damage of brain tissue.
Continuous monitoring of ICP had been established clinically by Guillaume and Janny, more than half century ago (1951) . Although more than one method of measurement had been clinically administered since the establis-
IX. MAINTENANCE OF CEREBRAL PERFUSION • RECOM MENDATIONS • A. Level I evidences
-There are insufficient data to support a Level I recomm endation for this topic.
• B. Level II evidences -A ggres siv e attempts to maintain cerebral perfusion pressure (CPP) above 70 mm Hg with fluids and press ors should be avoided because of the risk of adult respirator distress syndrome (ARDS).
• C. Level III evidences -CPP of < 50 mm Hg should be avoided.
- 
Clinical utility of ICPinormation
There yet has been a controversy about threshold ICP value above which it becomes harmful for brain structures. The majority of clinicians approve only values within normal range (15 -20 mmHg) . There is no general correlation between ICP increase and the emergence of clinical neurological lesion.
As in patients with benign intracranial hypertension, relevant increase of ICP will not provoke significant neurological disruption. On the other side, head trauma may be accompanied by moderate increase of ICP and have a lethal outcome consequently. (Picture 3).
Intracranial pressure monitoring
By anatomical localization consequent methods for ICP measurement are:
• epidural,
• intraventricular and • intraparenchymatous monitoring. Methods applied for ICP monitoring have been based on measurement of hydrostatic pressure of liquid connected with external transducer or implanted microsensor, placed directly in brain tissue, epidural or subdural space, or through catheter placed in intraventricular space.
Monitoring through intraventricular catheter has been approved as golden standard because of high accuracy and ability for therapeutical drainage of liquor. The possibility of reiterated calibrations of catheter in situ is not only one of desirable benefits. The drawbacks of this form of monitoring consequently are:
• More prevailing risk of complications, compared with other methods of monitoring (hemorrhage 1 -2 %, infections 8 -10 %);
• Cumbersome placement of catheter in situation of brain edema or narrow ventricles;
• Likelihood that catheter could be obstructed by blood clot or tissue debris;
Epidural, subdural and subarachnoid monitoring techniques are mutually comparable. They are less invasive than intraventricular method, so the frequency of complications is somewhat lower. The placement is easier, but their accuracy is not satisfying, they are susceptible to damaging, so they are utilized infrequently.
Parenchymatous sensor method of measurement presents itself as the best alternative to ventricular monitoring, especially when the placement of ventricular catheter had been unsuccessful or there has been possibility that catheter would have been blocked. Parenchymatous sensor is convenient for application and remarkably accurate. The complications are less frequent than with intraventricular method of measurement. The limitations are: inability to drain liquor, the sensor is rather expensive and, again, the incapability for reiterated calibrations of catheter in situ.
Recognizing benefits and limitations of different monitoring techniques enables the clinician to adopt the ICP monitoring method most convenient for individual patient. Something should be always kept in mind: "No monitoring is less harmful for the patient than inaccurate ICP monitoring" 14 .
The question: "when the ICP monitoring should be discontinued and how long it should be kept in situ?" has still not been clarified. Theoretically, the ICP monitoring should be ceased after stabilization of pressure within normal range of values, in 48 -72 h, following complete cessation of specific treatment for intracranial hypertension. Whereas there is possibility of infection, especially in intraventricular method of measurement, the majority of authors do not recommend continuation of the monitoring over 7 days. However, there have been authors who sustain the monitoring over 2 weeks.
Fluid demands of patients with intracranial comorbidities
Patient with brain disease mostly doesn't differ from healthy person by his daily water demands. If the patient has been oliguric it can be understood as a consequence of dehydration treatment that he had soon been admitted owing to the need for reduction of intracranial hypertension. In a patient with head trauma oliguria can indirectly indicate 
Patient's electrolyte demands
Diuretics have frequently been used to treat intracranial pathological processes, but that increases the loss of electrolytes. By combined treatment, applying 20% solution of mannitol and some diuretic of Henle's loop concomitantly, excretion of sodium ion (Na + ) will be increased 5 times, and of potassium ion (K + ) 3 times in regard to the usage of sole mannitol solution. In addition, patient with syndrome of intracranial hypertension may lose significant quantity of K + and H + ions by "central" vomiting and it may culminate with hypokalemic alkalosis.
Osmotic diuresis
Increase of plasma osmolality and creation of osmotic gradient between brain tissue and blood has been the rational base for utilizing hypertonic solutions to diminish the brain volume and to decrease ICP. Mannitol as a 20% solution has long been primary tre-atment of brain edema. It doesn't metabolize in body and doesn't penetrate intact blood brain barrier (BBB). Dama-ged BBB elicits mannitol to penetrate into the brain tissue and to move water along new osmotic gradient. Whereas mannitol dehydrates healthy brain regions, the greater volume of damaged brain tissue is, the smaller effect of ma-nnitol on ICP decrease will be. If the area of damaged BBB is extremely great, the "rebound" effect of mannitol may be seen. The treatment with mannitol longer than few days is irrational. Whereas mannitol doesn't treat the origin of pathological brain process, but only the symptom -increased ICP, so after its prolonged application there may be seen the stable increase of brain tissue osmolality. Na + , K + ions and free amino acids penetrate into the neurons and glial cells, also increasing the intracellular osmolality 2, 15 . The result is diminishing effect of mannitol on increased ICP.
The treatment with mannitol elicits important metabolic consequences. Osmotic diuresis elicited by mannitol evokes the excretion of significant quantities of Na + and K + ions. This can be disguised by their normal (even increased) plasma values in hypovolemic patient. Diuretics of Henle's loop (furosemide, bumetanide) have been adjuvants in forcing acute brain dehydration. Some authors even recommend them as alternative to mannitol, considering avoidance of potential undesirable effects of mannitol infusion (initial increase of ICP and acute electrolyte imbalance) after their application 16 .
THE EFFECTS OF ANESTHETICS ON CENTRAL NERVOUS SYSTEM
Anesthetic procedures and applied anesthetic drugs significantly influence CBF and brain metabolism, directly or indirectly. Volatile anesthetics, exerting direct vasomotor action, elicit the expansion of blood vessels -vasodilatation. Majority of hypnotics (barbiturates, propofol, etomidate) and opiates act in contrast -as vasoconstrictors.
Whilst barbiturates keep direct correlation between alteration of CBF and brain tissue metabolism, halogenated carbohydrates (enflurane, isoflurane, sevoflurane) violate that correlation, i.e., as CBF increase, brain metabolic processes diminish.
Intubation, respiratory depression (hypercapnia), chest wall rigidity (after admitting opiates) -are the examples of anesthetic procedures that elicit increase of ICP.
Nevertheless exact mode of anesthetic action on CNS has not been completely understood, the effects of their appliance are dose-dependent and subject to modification by other factors like: pH of blood, body temperature, coexistence of preceding neurological illness, etc.
All inhalational anesthetics generally may be considered as cerebral vasodilators, which mean having potential to increase ICP. Likewise, all inhalational anesthetic drugs, with possible exception of nitrous oxide, decrease the brain metabolic rate.
Intravenous anesthetic drugs act mostly as cerebral vasoconstrictors, diminishing simultaneously the brain metabolic rate. The exact mechanism of cerebral vasoconstriction is indirect for the majority of those agents. Depression of the brain metabolism, as primary effect of intravenous agents, elicit decrease of CBF as a secondary consequence. The exception within hypnotic agents is ketamine that acts stimulating brain metabolism and increasing CBF consequently.
Benzodiazepines elicit decrease of CBF and CMRO2 that doesn't proceed some 25% for diazepam, while for midazolam is somewhat more intense (about 30%). Midazolam provides good hemodynamic stability, diminishes mean arterial pressure less, thereby also CPP, than pentothal. In hypoxic/ischemic conditions it exerts protective effect on brain.
α2 adrenoceptor agonists (alpha-2 agonists) elicit neuroprotective effect, that has been demonstrated experimentaly 17 . Clonidine and dexmedetomidine, as representatives of a group, act diminishing the increase of catecholamines in circulation after generation of experimental ischemic lesion 18 . Nevertheless, the neuroprotective effect of alpha-2 agonists has still not been confirmed in human medicine.
THE EFFECTS OF SPECIAL ANESTHETIC TECHNIQUES ON CENTRAL NERVOUS SYSTEM Hyperventilation
Hyperventilation is considered to be a state where the enhanced volume of air (or gas mixture) is inserted into the alveoli of lungs. Diminishing of PaCO2 and, eventually, alkalosis of blood are the consequences of hyperventilation. Hyperventilation is one of the most important tools in the treatment of increased ICP, especially when its urgent decrease is necessary as it is the case in acute herniation of a part of the brain. The principle of hyperventilation effect is consequence of Monro-Kellie's doctrine: "...the content of cranial cavity as a three-chamber Br. 2 Preoperative assessment and preparation of patients with 87 diseases affecting the central nervous system system". There are stable 1,600 mL (averagely) of total content within rigid cranial cavity. Three components of that content are:
• Brain tissue (84%), cerebrospinal fluid (12%) and blood (4%).
Addition of new component (hematoma, tumor, brain tissue edema) violates volume balance of three-chamber system and generates the increase of arterial pressure (Cushing's reflex), as a first pathophysiologic reaction. Volume decrease of any system component acts as potentially compensatory mechanism.
Hyperventilation, by its physiologic effects (drop of PaCO2 and consecutive decrease of CBF), extremely rapidly ameliorates intracranial hypertension. Unfortunately, duration of this cerebral circulation protective reaction is limited. There is almost no doubt that desirable effect of decreasing volume of blood in the brain is lost within 24 -36 h, resulting in that prolongation of hyperventilation regime over that interval would be irrational, especially having in mind the possibility of developing cerebral ischemia as adverse consequence of forced hyperventilation 19 . During continuous hyperventilation, after initial drop of ICP, slow, newly increase of ICP arises within 3 -5 h and it stabilizes at the level usually lower than average values of ICP before hypocapnia commencement 20 . Hyperventilation makes sense only in patients with preserved autoregulation of blood circulation. In diseases where the autoregulation has been disabled (i.e., cerebral ischemia) CBF in ischemic region commences directly to follow alterations in mean arterial pressure, not in PaCO2. Clinical consequences of lost autoregulation had been denominated as intracerebral steal syndrome and countersteal syndrome -or Robin Hood syndrome. By the term steal syndrome reaction of CBF to increased PaCO2 phenomenon has been described, whereas blood run away from ischemic brain region to healthy one. Countersteal implies the reaction of CBF to the drop of PaCO2, whereas blood is directed from the healthy region of the brain to the ischemic one 21 . It has been considered that "steal" phenomenon plays the role in the effects of secondary vasospasm after subarachnoid hemorrhage. Attempt to treat the spasm with hypoventilation (increase of PaCO2), to elicit forced vasodilatation of arteries in spasm, results in deterioration without exception 22 . Obviously the autoregulation is lost in the area of secondary spasm. In normal regions, with preserved autoregulation, hypoventilation (hypercapnia) evokes vasodilatation and increase of rCBF, stealing blood from the areas in spasm. However, there have been no certain evidences of better outcome neither after treating patients with ruptured aneurysm or cerebrovascular occlusive disease with hyperventilation (hypocapnia). The rational base for specific therapeutic procedure exists in the "countersteal" phenomenon. Apparently the basic problem is the harmful effects of hyperventilation, prolonged over 24 -36 h. After that period hyperventilation (unless sui generis, it doesn't elicit vasoconstricting effects of brain tissue ischemia) evokes decrease of venous blood return into the heart and consequential increase of cerebral venous pressure, leading to global, ischemic reduction of CBF. Possible solution could be appliance of high-frequency jet ventilation that would provide hyperventilation with less biomechanical consequences on venous blood return into the heart 23 . If the hypocapnia is followed by hypoxia, cerebral vascular response to hypocapnia could be completely absentit is the explanation for the inefficiency of spontaneous neurogenic hyperventilation of patients with the brain stem lesion in diminishing the increased ICP. Unconscious patients breathing deeply and rapidly (lesion in the mesencephalic area) decrease their own PaCO2, shifting oxygen dissociation curve "to the left" and, as a consequence, protracting the delivering of oxygen to brain tissue. The tissue hypoxia arise acting as vasodilator to brain blood vessels and preventing the ICP drop. The artificial hyperventilation (by mechanical ventilator) will compromise tissue oxygenation by the same mechanism -if it is prolonged, continuous and forced.
Severe hyperventilation (with diminishing of PaCO2 to the range of 20 -25 mmHg) extremely rapidly decreases ICP and is applied only in urgent situations of suddenly originated vasogenic brain edema, when fast and transient reduction of ICP is necessary. In the Intensive care unit, where the prolonged treatment of intracranial hypertension is necessary, the mild hyperventilation, in the range of 30 -35 mmHg, is more reliable because it induce tissue hypoxia more slowly and is equally efficient in long-term stabilization of ICP as extreme hypocapnia 2, 4, 15, 16, 24 . Moderate hypocapnia (25 -30 mmHg) has mostly been hazardous as prolonged treatment and would be admitted only in intraoperative procedure of routine preparation of the brain for surgical intervention where the optimal monitoring options are available: ICP, PaO2 and PaCO2. The reason is in pathophysiologic data that PaCO2 lower than 30 mmHg doesn't decrease attained gauge of brain blood vessels any more, but diminish the velocity of circulation (increasing the cerebral venous pressure, the "time of circulation" is prolonged) accordingly 25 -26 .
CONCLUSION
Considering patients with diseases affecting the central nervous system who may undergo various forms of surgery unrelated to the cranial cavity we have to resolve some key questions: what brain disease we are talking about, did we provide the consultative exam of a neurologist and/or neurosurgeon, did we explained all characteristics of the coexisting brain disease providing information about: intracranial hypertension, cerebral circulation irregularities, and alterations in cerebral metabolic rate. Thereafter, we have to consider if adequate monitoring techniques are provided, including: transcranial Doppler ultrasound, ICP measurement (parenchimatous or intraventricular), monitoring of anesthesia depth (BIS), monitoring of somatosensory and/or motor evoked potentials. Does the applied anesthetic technique influence the information provided with the monitoring procedure? Finally, the therapeutic regimens on disposal for treating various forms of intracranial pathophysiologic conditions has to be consid-
